Background: Carbohydrate-deficient transferrin (CDT) is a biochemical marker used for identifying chronic alcohol intake. We developed and validated an ARCHITECT c8000 (Abbott) instrument application for the Axis-Shield %CDT immunoassay.
Methods: Standard CLSI (Clinical and Laboratory Standards Institute) evaluation protocols were performed.